Emicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trials

Víctor Jimenez-YusteJohannes OldenburgEunice TzengElise LimFabian SanabriaJohnny Mahlangu2024-10-182024-10-18WOS2475-0379https://hdl.handle.net/10539/41704Emicizumab is efficacious in people with Hemophilia A with comordities aged less than 50 years analysis of 4 phase III trialsJournal Article